Pre-Open Movers: One Medical Surges on Amazon Takeover, Carnival Falls on Stock Offering

Morgan Stanley Comments on Tesla (TSLA)

Morgan Stanley analyst Adam Jonas reiterated an Overweight rating and $1,150.00 price target on Tesla (NASDAQ: TSLA).

The analyst comments "Tesla will exit FY22 at nearly a 2mm annualized run-rate. They should be double that within 2 to 3 years. But size brings complexity in autos and... More

Tesla (TSLA) PT Raised to $410 at JPMorgan, Remains Underweight

JPMorgan analyst Ryan Brinkman raised the price target on Tesla (NASDAQ: TSLA) to $410.00 (from $385.00) while maintaining a Underweight rating.

The analyst comments "Our Underweight rating considers notable investment positives, including a highly differentiated business model, appealing product portfolio, and leading-edge technology, which we believe... More

Cowen has 'a thesis that many primary-care VBC companies could be acquired by health insurers over the next several year'

Cowen analyst Gary Taylor comments "We have a thesis that many primary-care VBC companies could be acquired by health insurers over the next several years as they seek the benefits of vertical integration and seek to compete with bellwether UNHs OptumCare division. However, despite its recent Iora Medicare Advantage... More

Stifel Reiterates Buy Rating on Amazon.com (AMZN), Sees Deal Expanding Co's Reach and Services of Amazon Care

Stifel analyst Scott Devitt reiterated a Buy rating and {REMOVEPT} price target on Amazon.com (NASDAQ: AMZN).

The analyst comments "We believe this acquisition will help expand the reach and services offered by Amazon Care. Amazon recently expanded its virtual care services across the... More

Evercore ISI Reiterates Outperform Rating on Amazon.com (AMZN), Says Deal is 'strategically sensible'

Evercore ISI analyst Mark Mahaney reiterated an Outperform rating and $180.00 price target on Amazon.com (NASDAQ: AMZN).

The analyst comments "As a quick first pass, we view Amazons announced acquisition of One Medical (ONEM) for $3.9B (all cash) as strategically... More

Stifel Reiterates Buy Rating on 1Life Healthcare Inc. (ONEM)

Stifel analyst Craig Jones reiterated a Buy rating and {REMOVEPT} price target on 1Life Healthcare Inc. (NASDAQ: ONEM)

The analyst offers quick thoughts on the acquisition "ONEM has obviously been in play, which implies others have evaluated the opportunity. As summarized in our previous... More

Evercore ISI on Amazon (AMZN) Acquiring 1Life Healthcare Inc. (ONEM): 'Wow!', Sees Deal as Modest Negative For CVS (CVS)

Evercore ISI analyst Elizabeth Anderson reiterated an In Line rating and $12.00 price target on 1Life Healthcare Inc. (NASDAQ: ONEM).

The analyst comments "Wow! With our healthcare lens, we were overly-focused here about the potential take out potential of ONEM by managed care. Todays announcement expands Amazons footprint in healthcare and adds physical clinics as well as payer and hospital system relationships to Amazons current telehealth capabilities as well as providing Amazon a well-known customer brand in the space. We would expect... More